Ma Huang.
Research-backed compound with potential health benefits. Stimulates central nervous system, increases metabolism, suppresses appetite. The source of pharmaceutical ephedrine.
Reviewed March 2026
- Category
- Compound
What Ma Huang is, and what it does.
- Does it work
- No. Too dangerous for supplements. Banned for good reason.
- How much to take
- Don't. If used medically, only under strict supervision.
- Time to feel it
- Ephedrine alkaloids are absorbed quickly, so the rise in heart rate, blood pressure and alertness usually shows within 30 to 60 minutes of a dose.
- The first dose
- Strong stimulation. Increased heart rate, energy, possibly anxiety and jitters.
- With regular use
- Cardiovascular damage risk. Not for long-term use.
- How well tolerated
- Not safe. Associated with deaths. Banned in US supplements since 2004.
- How it feels
- Powerful stimulation. But also potentially dangerous heart racing and anxiety.
- The overlooked benefit
- Part of the effect comes from releasing stored noradrenaline, so the same amount does less as that store runs down. The fading response is chemistry, not something to push through.
200 to 500mg a day is where Ma Huang works.
Source: Shekelle et al., JAMA 2003; FDA ban on ephedra dietary supplements 2004
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Ma Huang is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Appetite suppression and energy expenditureMeta-analysis
- Relaxation of bronchial smooth muscleNarrative review
- Short-term exercise outputRandomised trial
- Rise in heart rate and blood pressure after dosingRandomised trial
Questions people ask about Ma Huang.
- Why is it banned?
- Multiple deaths and serious cardiovascular events. FDA banned ephedra supplements in 2004.
- Is it still available?
- As a TCM herb in some contexts. Not as a weight loss supplement in US.
- What about ephedrine-free versions?
- Those don't contain ma huang. They use other stimulants that are less dangerous.
- Did athletes use it?
- Yes, before the ban. Many athletic associations also prohibit it.
- Are there safer alternatives?
- For weight loss: green tea, caffeine. For energy: caffeine, B vitamins. Much safer.
- Why mention it if it's dangerous?
- Education. People still encounter it. Understanding the risks matters.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Ephedra alkaloids release noradrenaline while caffeine blocks adenosine receptors and slows cyclic AMP breakdown, so the two raise the same second messenger by different routes. The combination is markedly more stimulating than either alone and raises heart rate and blood pressure additively.
Anhydrous caffeine reaches peak blood levels quickly, sharpening the overlap with an ephedra alkaloid dose. The additive rise in heart rate and blood pressure is the reason this pairing needs a deliberate dose decision.
Guarana seed is a concentrated caffeine source with a slower release from its tannin matrix, extending the window over which stimulant effects overlap with ephedra alkaloids.
Yerba mate carries caffeine plus theobromine, both methylxanthines acting on adenosine receptors and phosphodiesterase. Its stimulant load adds to that of an ephedra alkaloid.
Green tea catechins inhibit catechol-O-methyltransferase, the enzyme that clears noradrenaline, while ephedra alkaloids release it. The result is a longer-lived adrenergic signal than either produces alone.
Both are indirect sympathomimetic amines that displace noradrenaline from nerve terminals, so their effects on heart rate and blood pressure stack on the same mechanism with no offsetting route.
Octodrine is an aliphatic amine acting as an indirect sympathomimetic in the same way ephedra alkaloids do. Stacking two agents on one mechanism compounds the cardiovascular response.
Octopamine is a trace amine with beta-adrenergic activity, overlapping directly with the receptors ephedra alkaloids reach through released noradrenaline.
Hordenine acts as an indirect sympathomimetic and slows monoamine breakdown, which extends the presence of the noradrenaline an ephedra alkaloid releases.
Theanine modulates glutamate and GABA signalling and blunts part of the blood pressure response to stimulants. It is added to sharp adrenergic formulas to soften the edge rather than to add to it.
Alkalinising the urine increases the un-ionised fraction of ephedrine in the tubule, which is reabsorbed rather than excreted. The result is a longer half-life and higher accumulated exposure from the same dose. Sodium bicarbonate is taken by some athletes for buffering, so the overlap is realistic rather than theoretical. This is an exposure change and is worth flagging in any stimulant formula.
The direction here is opposite to alkalinisation: a more acidic urine traps the ionised form and speeds excretion. Ordinary supplemental ascorbate shifts urinary pH only modestly, so the practical size of the effect is small. It is included because the mechanism is the same one that makes bicarbonate matter. The same is true in the other direction for any acidifying agent.
Ephedra alkaloids act as sympathomimetics and raise blood pressure and heart rate. Glycyrrhizin raises blood pressure through a completely separate mineralocorticoid route. Two independent pressor mechanisms in one formula add up, and the potassium loss from glycyrrhizin compounds the picture. This is an interaction to avoid rather than a pairing to build.
Blocking the presynaptic alpha-2 autoreceptor removes the brake on noradrenaline release, while ephedra alkaloids drive that release directly and also stimulate the receptors. The two mechanisms converge on the same sympathetic output. Combined use amplifies heart rate, blood pressure and anxiety responses. Flagged as an additive cardiovascular effect.
Ephedra alkaloids work partly by releasing stored noradrenaline from nerve terminals. Tyrosine supplies the substrate from which that store is rebuilt through tyrosine hydroxylase and dopamine beta-hydroxylase. Formulators pair them on that substrate logic. Precursor supply is not the rate-limiting step under ordinary conditions, so the practical size is uncertain.
Dopamine beta-hydroxylase is a copper enzyme that requires ascorbate as its reducing cofactor. Noradrenaline cannot be made from dopamine without it. That places ascorbate upstream of any agent that depends on catecholamine stores. It is a cofactor relationship rather than a stimulant effect.
The copper centre is what performs the hydroxylation that converts dopamine into noradrenaline. Without adequate copper the enzyme cannot function regardless of substrate supply. This is standard trace-metal enzymology. It is a cofactor note, not a reason to combine the two in a stimulant product.
Sympathomimetic stimulation increases cardiac work and shifts potassium intracellularly, and magnesium status underlies normal rhythm handling. The relationship is opposing rather than additive. It does not make a stimulant combination benign and should not be read that way. The point is that electrolyte status is part of the cardiovascular picture.
Beta-2 agonism is a recognised cause of a transient drop in serum potassium, and ephedra alkaloids have beta-2 activity. Combining them with anything else that lowers potassium, such as glycyrrhizin or a diuretic herb, compounds the shift. Potassium is listed here as the affected electrolyte, not as a countermeasure. This belongs in a clinician conversation.
Sympathomimetics raise arousal and delay sleep onset; melatonin acts on the circadian timing signal. Taken together they pull in opposite directions rather than cancelling neatly, since the receptor systems are unrelated. This is a formulation conflict worth naming. It is not a pairing with a combined benefit.
Rhodiola is commonly stacked into energy formulas alongside stimulants. Its reported activity involves monoamine handling, which is the same broad system ephedra alkaloids act on directly. The combination adds stimulation of an uncertain size rather than acting through separate routes. Anyone sensitive to stimulants should read it that way.
Nothing specific on file for Ma Huang. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Ma Huang actually does.
Ma huang is the dried stem of Ephedra sinica and related species. Its characteristic constituents are the phenylalkylamine alkaloids ephedrine and pseudoephedrine, with smaller amounts of methylephedrine, norephedrine and norpseudoephedrine.
Ephedrine is a mixed-acting sympathomimetic: it displaces noradrenaline from presynaptic vesicles through the noradrenaline transporter and also stimulates alpha and beta adrenergic receptors directly.
Because part of the effect depends on releasing stored noradrenaline, repeated dosing produces tachyphylaxis as the releasable pool is depleted, and the same dose produces a smaller response.
Beta-1 stimulation raises heart rate and cardiac contractility while alpha-1 stimulation constricts peripheral vessels, so the cardiovascular signature is a rise in both heart rate and blood pressure.
Where Ma Huang comes from.
The green stems of the ephedra shrub are cut and dried, then soaked in water or weak alcohol to pull out the active alkaloids. Makers wanting a concentrate move those alkaloids between acid and base solutions to separate them from the rest of the plant, then lab-test each batch for how much ephedrine it holds. How much of this may be sold in a supplement is set by law and differs from country to country.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
The green jointed stems of a low shrub from arid regions of northern China, Mongolia and central Asia. The root is a separate traditional material and is not used for this.
Stems are harvested, cut to lengths and dried; alkaloid content depends on species, harvest timing and which part of the stem is taken.
Milled herb is extracted with water or dilute alcohol; the alkaloids are water-soluble bases and partition readily into an acidified aqueous phase.
Where an alkaloid concentrate is made, the extract is acidified to hold the alkaloids as salts, washed, then basified so the free bases move into an organic phase.
Batches are assayed for ephedrine, pseudoephedrine and minor alkaloids and blended to a declared total.
The dried herb or concentrated extract is milled and filled. Regulatory status for ephedrine-alkaloid-containing supplements differs by country and is a legal question rather than a manufacturing one.
Getting Ma Huang from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Problems people have reported.
Read this carefully. These are 94 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Ma Huang is, not how risky it is. A report is not proof Ma Huang caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.